Pfizer to improve consumer advertising for prescription medicines

MUMBAI: In order to meet patients' and physicians' needs for health information efficiently, pharmaceutical major Pfizer Inc is planning to change its direct-to-consumer (DTC) advertising of prescription medicines.

The full set of changes will be in place in all Pfizer advertising directed to consumers before the end of 2005, with many of them taking effect immediately.



Pfizer's ads will be consistent with the recently announced pharmaceutical industry's "Guiding Principles" on DTC advertising, which were adopted by the Pharmaceutical Researchers and Manufacturers Association (PhRMA) on 2 August.

The Pfizer changes are designed to help patients achieve better health by encouraging valuable patient/physician dialogue, improving consumer understanding of the risks and benefits of prescription medicines, and motivating people to overcome barriers to healthy behavior.



"DTC advertising is demonstrably helpful to patients, but it should be refined to be even more helpful. DTC ads have encouraged millions of patients to get earlier medical attention and to talk with their healthcare providers. The problem it addresses is real: too many Americans who need medical help postpone action, suffer unnecessarily, delay treatment until their health deteriorates, and end up suffering higher medical costs and more-acute interventions than necessary. Today, we're announcing changes to our DTC advertising to strengthen its educational benefits?and to motivate patients to take earlier action and work with their healthcare providers to take more-informed control over their health," said Pfizer Human Health vice chairman and president Karen Katen.



Studies have shown that consumers want and need health information to better engage in today's health care environment. But significant barriers still prevent tens of millions of Americans from taking action around their health, especially for serious medical conditions such as high cholesterol, high blood pressure, depression, asthma and diabetes. These barriers include lack of awareness, denial, misinformation, low health literacy (inability to understand medical information), perceived stigma and lack of insurance coverage for prescription medicines. A strong record of research shows that DTC advertising can be an effective vehicle for getting important health information to consumers and motivating them to consult their doctors.

In fact, over 65 million patients have talked with their physicians after seeing a DTC advertisement and 29 million of these patients mentioned a condition for the first time, according to a 2004 Prevention magazine study.

Moreover, DTC advertising has helped one in four patients who asked about a DTC advertised product during a doctor visit get a diagnosis for a previously unknown medical condition; approximately 43 per cent of these new diagnoses were for high priority conditions such as asthma, high blood pressure or diabetes (Harvard University and Harris Interactive).

Advertising Changes

Since Pfizer started advertising to consumers on television in 1998, the company has regularly consulted with physicians and patients to better understand what is working and how DTC advertising can have a greater impact on healthy behavior. Based on this input, Pfizer makes its patient health information more understandable and easier to read in accordance with its Clear Health Communication Principles.

Now, Pfizer is announcing changes to its advertising in three major areas, as well as announcing additional actions, all of which are consistent with the industry's "Guiding Principles" recently adopted by PhRMA.

"Our advertising is meant to do two things. We want people to be aware of serious medical conditions and our medicines that treat those conditions, and we want to motivate them to talk to their doctors. We believe it's our responsibility to communicate this information effectively so patients can work with their healthcare providers to make informed decisions about their health and get appropriately diagnosed and treated," said Pfizer US Pharmaceuticals president Pat Kelly.

Listed below are the improvements Pfizer is making to its consumer advertisements:

    To help encourage valuable patient/physician dialogue that can lead to early diagnosis and appropriate treatment, Pfizer will: educate physicians about new prescription medicines prior to beginning product TV and print advertising so that doctors can be well-informed about a new medicine before patients start conversations about it. The length of time used for physician education will be no less than six months and will vary depending on the relative importance of informing patients of the availability of a new medicine, the complexity of the risk-benefit profile of that new medicine and health care providers' knowledge of the condition being treated. It will also include language in its product TV and print ads and on product Web sites informing patients that their doctors may recommend alternative treatments, such as diet and exercise, when appropriate.

    To help consumers better understand the risks and benefits of prescription medicines, Pfizer: will fundamentally change our approach to communicating risk and benefit information to improve educational value while continuing to motivate people to overcome barriers to healthy behavior. Pfizer has submitted to the FDA for review a new consumer-friendly and consumer-tested print brief summary, the part of the print ad that extensively lists the risks of a medicine. Should the FDA approve this new version, Pfizer will use this new format in all its print advertising and on all of its product Web sites. Pfizer will fund research to find ways to further improve risk communication in DTC TV advertising. We will conduct this research with input from the FDA and third parties and will adjust Pfizer's communications based on the results. The company will provide use, risk and benefit information in all product TV and print prescription medicine advertisements. This means Pfizer will no longer create "Go ask your doctor about a medicine" TV and print advertisements that do not include the benefits and risks associated with the advertised medicine. In cases where a product is mentioned as part of a sponsorship package, such as "This event is brought to you by Brand X," risk and benefit information will not be included because these communications are about support for the sponsored entity, not the Pfizer product.

    To motivate people to overcome potential barriers to better health, starting immediately, Pfizer will: include information about the industry's "Partnership for Prescription Assistance (PPA)" in a new dedicated "Pfizer Helpful Answers" TV and print ad campaign. PPA offers a single point of access to more than 275 public and private patient assistance programs, including more than 150 programs offered by pharmaceutical companies. The company will also air a dedicated, nationwide TV and print advertising campaign promoting "Pfizer Helpful Answers" to raise awareness among Americans without prescription coverage about Pfizer's patient assistance programs that provide savings on Pfizer medicines or Pfizer medicines for free, depending on income. Pfizer will include "Pfizer Helpful Answers" contact information in all Pfizer product print ads and Web sites. It will also educate doctors, other healthcare providers and their office staff on Pfizer patient assistance programs.

In 2006, Pfizer will invest a meaningful amount - on par with what it spends on a branded advertisement campaign - to create more disease awareness with advertisements that do not mention a product, such as the recent "Why Live With Depression" campaign that featured actress Lorraine Bracco.

The company will also address other important public health issues such as health literacy, compliance or improving the patient/physician relationship through additional non-product advertising and continue our dedicated advertising campaign and efforts to promote "Pfizer Helpful Answers."

In addition to the three areas of change, Pfizer also commits to:

    Submit to the FDA for review all new DTC TV ad campaigns, and those that have major changes, for comment in advance of airing.

    Review the placement of our current advertising to ensure that it will be targeted to avoid audiences that are not age appropriate. For erectile dysfunction ads, this means that all TV ads will be aired during programs that have more than 90 per cent adult viewership.

    Clearly indicate in all product TV and print ads that the medicine is a prescription medicine.

Latest Reads
Yamaha's 'The Call of the Blue' is launched as the new exciting brand campaign

India Yamaha Motor Pvt. Ltd. developed its new brand campaign ‘The Call of the Blue’ in order to draw a parallel to its product planning, marketing and customer engagement strategies with the brand’s global image of ‘excitement, stylish and sporty’.

MAM Media and Advertising Ad Campaigns
Isuzu Motors signs Jonty Rhodes as Indian brand ambassador

Isuzu motors, Japanese car manufacturer, has signed on former South African cricketer Jonty Rhodes as the brand ambassador to promote the brand and its latest product V-Cross in India. The brand will complete six years on 21 August 2018 in the Indian market.

MAM Media and Advertising People
UCB's first social experiment in India #UNITEDBYHOPE

Reaffirming its commitment to challenge social norms and fearlessly address issues focused on secularism and non-discrimination, United Colors of Benetton marked India’s 72nd Independence Day with a digital film titled #UnitedByHope, celebrating India’s unity in its diversity.

MAM Marketing MAM bolsters senior management team to pursue expansion plan

To pursue its ambitious growth and expansion plans, recently strengthened its senior management team with experienced talent.

MAM Marketing MAM
The Advertising Club announces the Category Awards for Marquees 2018

The Advertising Club today announced the various sector and special category awards for Marquees 2018.

MAM Marketing MAM
White Rivers Media celebrates 6th anniversary

In India, one of the fastest growing independent agencies White Rivers Media has recently completed its six years in social media and digital marketing industry.  

MAM Marketing Brands
The Minimalist strengthens leadership team

The Minimalist, one of the fast-growing design and digital companies, has boosted it leadership team with the appointment of head of interaction design Rohan Saraf, lead, user interface Amit Rajapurka.

MAM Media and Advertising People
WATConsult bags Domino’s India’s digital media mandate

WATConsult, the digital and social media agency from Dentsu Aegis Network India, has recently won the social media mandate for Domino’s.

MAM Media and Advertising Account
Ad industry calls for regulatory body to monitor plagiarism

Creativity sometimes takes inspiration from past creatives but what if it is an entirely copied one? Plagiarism (or inspiration), is a never-ending burning issue in the advertising world. A little similarity can be overlooked but complete knockoffs are just astonishing.

MAM Marketing MAM

Latest News

Load More

Sign up for our Newsletter

subscribe for latest stories